K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.4 HKD 0.47%
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Kangji Medical Holdings Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kangji Medical Holdings Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
K
Kangji Medical Holdings Ltd
HKEX:9997
Other Operating Expenses
ÂĄ51.1m
CAGR 3-Years
68%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Other Operating Expenses
ÂĄ370.4m
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Other Operating Expenses
-ÂĄ26.6m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Autobio Diagnostics Co Ltd
SSE:603658
Other Operating Expenses
ÂĄ59.1m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Other Operating Expenses
ÂĄ97m
CAGR 3-Years
12%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Other Operating Expenses
ÂĄ32.3m
CAGR 3-Years
32%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.32 HKD
Undervaluation 38%
Intrinsic Value
Price
K

See Also

What is Kangji Medical Holdings Ltd's Other Operating Expenses?
Other Operating Expenses
51.1m CNY

Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Other Operating Expenses amounts to 51.1m CNY.

What is Kangji Medical Holdings Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
18%

Over the last year, the Other Operating Expenses growth was 93%. The average annual Other Operating Expenses growth rates for Kangji Medical Holdings Ltd have been 68% over the past three years , 18% over the past five years .

Back to Top